Chlorpromazine combined with cidofovir for treatment of a patient suffering from progressive multifocal leukoencephalopathy
Research output: Contribution to journal › Research article › Contributed › peer-review
Contributors
Abstract
We report on a stem cell-transplanted patient with B cell chronic lymphatic leukemia who presented with a subacute onset of focal neurological deficits, gait abnormalities, emotional lability and dementia. Progressive multifocal leukoencephalopathy was diagnosed by magnetic resonance imaging (MRI) of the brain and detection of JC virus genome in the cerebrospinal fluid. Cidofovir and the 5HT2A receptor antagonist chlorpromazine were subsequently administered. A follow-up MRI of the brain 2 weeks after initiation of the antiviral therapy displayed progress of the demyelination, and the patient died 3 months after onset of the neurological symptoms. This report highlights the need for the development of novel and potent strategies for treatment of progressive multifocal leukoencephalopathy.
Details
Original language | English |
---|---|
Pages (from-to) | 412-417 |
Number of pages | 6 |
Journal | Intervirology : international journal of fundamental and medical virology |
Volume | 50 |
Issue number | 6 |
Publication status | Published - Feb 2008 |
Peer-reviewed | Yes |
External IDs
Scopus | 39749191853 |
---|---|
PubMed | 18182774 |
Keywords
Sustainable Development Goals
ASJC Scopus subject areas
Keywords
- Chlorpromazine, Cidofovir, JC viral load, Progressive multifocal leukoencephalopathy